TrivarX

TrivarX Enterprise Value

The Enterprise Value (EV) of TrivarX (TRI.AX) as of Oct 27, 2026 is 26.53 M AUD. In the previous year, Enterprise Value (EV) was 27.76 M AUD — a change of -4.46% (lower).

Enterprise Value

26.53 MAUD

YoY

-4.46%

Last updated:

Enterprise Value (EV) of TrivarX is 2026 26.53 M AUD. Enterprise Value (EV) of TrivarX was 2025 27.76 M AUD. It decreases by -4.46% lower compared to the previous year.

The TrivarX Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
30.26 M AUD
Jan 1, 2020
28.11 M AUD
Jan 1, 2021
26.56 M AUD
Jan 1, 2022
27.88 M AUD
Jan 1, 2023
28.73 M AUD
Jan 1, 2024
28.01 M AUD
Jan 1, 2025
27.76 M AUD
Jan 1, 2026
26.53 M AUD
The TrivarX Enterprise Value history
YEAREnterprise ValueYoY
26.53 MAUD-4.46%
27.76 MAUD-0.88%
28.01 MAUD-2.51%
28.73 MAUD+3.07%
27.88 MAUD+4.97%
26.56 MAUD-5.52%
28.11 MAUD-7.12%
30.26 MAUD+32.50%
22.84 MAUD-4.70%
23.96 MAUD-23.91%
31.50 MAUD-0.30%
31.59 MAUD+3.10%
30.64 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TrivarX Stock analysis

What does TrivarX do? TrivarX Ltd generates revenue through its corporate health product, which provides mental well-being solutions for businesses. The company develops and commercializes mental health technology using objective biomarkers for screening, diagnosing, monitoring, and managing depression. Its consumer mobile application LUCA offers biometric assessments measuring sleep stress, activity stress, and cardiac stress, enabling users to monitor stress levels via personal wearable devices. The company focuses on early detection and screening of mental health conditions through clinical research and product development. The primary buyers of TrivarX's corporate health product are businesses seeking mental well-being solutions for their employees. The consumer application LUCA targets individuals interested in monitoring their stress levels using wearable technology. TrivarX's technology is designed to assist in the early detection and screening of mental health conditions, with a focus on depression management through objective biomarker analysis. The company's clinical research and product development activities support both business and consumer segments in the mental health technology market. TrivarX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TrivarX stock

Enterprise Value (EV) of TrivarX is 26.53 M AUD in 2026.

Enterprise Value (EV) of TrivarX changed from 27.76 M AUD to 26.53 M AUD, representing a -4.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) TrivarX since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s AUD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' AUD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s TrivarX with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — TrivarX

All Key Metrics — TrivarX